arkivnord

Idorsia Pharmaceuticals Nordics AB

Är verksam

5594104522 · Annan naturvetenskaplig och teknisk forskning och utveckling · SOLNA

Company information

Reg. no.5594104522
Legal formAktiebolag
Industry (SNI)Annan naturvetenskaplig och teknisk forskning och utveckling
Registered2022-12-07
AddressGustav III:s Boulevard 46, 16973 SOLNA
PhoneNot reported
F-taxÄr registrerad för F-skatt
VAT registeredÄr registrerad för moms

Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.

Financial summary

Fiscal 2025 brought revenue growth of 43.2 %, to 31.8 MSEK. Each of the three most recent comparable fiscal periods (2023–2025) ended in profit. In 2025, net sales corresponded to roughly 6.4 MSEK per employee (5 employees).

Calculated by ArkivNord from filed annual reports. About the methodology

Classifications

Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge.

Key figures (fiscal year ending 2025-12-31)

Net revenue

31.8 MSEK

+43%

Net result

0.1 MSEK

80%

Employees

5

+25%

Financial development

Annual reports

Annual report as of 2025-12-31

XHTML · 132 kB

Download

Annual report as of 2024-12-31

XHTML · 129 kB

Download

Annual report as of 2023-12-31

XHTML · 113 kB

Download

Management

Per the signatures in the annual report for the fiscal year ending 2025-12-31.

Antje DoetherOrdförande
Bettina BlosseVerkställande direktör
Patrick MillerRole unknown
Per HammarAuktoriserad revisor

This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.